Biofrontera Inc. Common Stock

BFRINASDAQUSD
1.22 USD
0.03 (2.52%)AT CLOSE (11:59 AM EDT)
1.23
0.01 (0.82%)
POST MARKET (AS OF 07:43 PM EDT)
Post Market
AS OF 07:43 PM EDT
1.23
0.01 (0.82%)
🔴Market: CLOSED

BFRI is currently priced at $1.24. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, BFRI appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Aug 4, 2026.

Open?$1.19
High?$1.26
Low?$1.18
Prev. Close?$1.19
Volume?516.3K
Avg. Volume?389.7K
VWAP?$1.22
Rel. Volume?1.32x
Bid / Ask
Bid?$1.06 × 100
Ask?$1.42 × 100
Spread?$0.36
Midpoint?$1.24
Valuation & Ratios
Market Cap?15.2M
Shares Out?12.8M
Float?11.3M
Float %?88.3%
P/E Ratio?N/A
P/B Ratio?2.51
EPS?-$0.87
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
Employees
94
Market Cap
15.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-10-29
Address
120 PRESIDENTIAL WAY,
WOBURN, MA 01801
Phone: 781-245-1325
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+3/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
0
Momentum?
8
Short Sent.?
75
Piotroski F-Score?3/9Weak
Altman Z-Score?-6.64Distress
Confidence?48%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.21%Low
Short Interest?24.2K
Days to Cover?1.0
Free Float11.3M
Avg Daily Volume437.6K
Settlement Date2026-07-15
Financial Health
Current Ratio?1.20Adequate
Quick Ratio?1.09Adequate
Cash Ratio?0.58Adequate
Debt/Equity?0.78Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
64
2.51CHEAP
P/S?
Peers
100
S&P
97
0.35CHEAP
P/FCF?
N/A
EV/EBITDA?
S&P
97
-1.3CHEAP
EV/Sales?
Peers
100
S&P
97
0.32CHEAP
Returns & Efficiency
ROE?
S&P
3
-182.6%WEAK
ROA?
S&P
3
-44.7%WEAK
Cash Flow & Enterprise
FCF?$-9318000
Enterprise Value?$13.6M
Fundamentals ratios updated end of day